Heart Disease Clinical Trials in Baltimore

Showing 461-480 of 505 trials

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

NCT01008670

The primary goal of this study is to develop techniques to identify the course of the phrenic nerve in patients already undergoing cardiac resynchronization therapy (CRT) implantation or candidates for future CRT devices undergoing implantable cardioverter-defibrillator (ICD) or pacemaker implantation. Specifically, the study intends to identify the location and course of the left pericardiophrenic vein, and thus the left phrenic nerve, to guide the location for coronary vein lead placement and minimize the risk of phrenic nerve stimulation.

Heart Failure

Respicardia, Inc.120 participantsStarted Dec 2007

Birmingham, Alabama, United States • Baltimore, Maryland, United States • Cincinnati, Ohio, United States +10 more locations

UNKNOWNPhase 1< 1 mile

Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant

NCT00364598

The purpose of this study is to obtain human heart tissue after treatment with Anginera to determine its effect on a variety of things that might indicate improvement in heart function. Patients who will have a left ventricular assist device (LVAD) implanted while they wait for a donated heart will be treated with Anginera. At the time of heart transplant, their diseased heart which is removed will be analyzed by microscopic examination to see what effect Anginera had.

Heart Failure

Theregen, Inc.15 participantsStarted Dec 2006

New Haven, Connecticut, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant

Heart Disease Trials in Other Cities

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Effects of Exercise on Patients With Hemiparetic Stroke

Cranberry Juice and Cardiovascular Disease

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks

Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women

Attain StarFix™ Model 4195 Left Ventricular Lead

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Other Conditions in Baltimore